This is quite some effort put in here and great European exposure for MSC’s used for aGVHD.
Who did the trial and who provided the product?
I am thinking there is definitely a European pharma or two waiting for Mesoblast’s FDA approval in the US to move forward in partnership for aGVHD in the European localities.
Cell Therapy News/Articles, page-17789
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.08 | $1.210M | 1.116M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 31072 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 115814 | 17 |
View Market Depth
| Last trade - 11.32am 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |